Symptomatic hypercalcemia in the first months of life: Calcium-regulating hormones and treatment

Journal of Endocrinological Investigation

Volumn 22, Issue 5, 1999, Pages 349-353

  Ghirri, Paolo ^a   Bottone, U ^a   Coccoli, L ^a   Bernardini, M ^a   Vuerich, M ^a   Cuttano, A ^a   Riparbelli, C ^a   Pellegrinetti, G ^a   Boldrini, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Calcium regulating hormones; Idiopathic infantile hypercalcemia; Neonatal hypercalcemia; Subcutaneous fat necrosis; Transient neonatal hyperparathyroidism; Williams syndrome

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CORTICOSTEROID; FUROSEMIDE; PARATHYROID HORMONE;

ARTICLE; CASE REPORT; DIET THERAPY; FACE MALFORMATION; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; MALE; NEWBORN; PATHOGENESIS; REHYDRATION; SUBCUTANEOUS FAT DISORDER; VITAMIN D INTOXICATION; WILLIAMS BEUREN SYNDROME;

EID: 0033001746     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343572     Document Type: Article

References (26)

1. Mimouni F., Tsang R.C. Parathyroid and vitamin D-related disorders. In: Kaplan S.A. (Ed.), Clinical Pediatric Endocrinology. W.B. Saunders Company, Philadelphia, 1990, p. 427-453.
2. Demarini S., Tsang R.C. Disorders of calcium and magnesium metabolism. In: Fanaroff A.A., Martin R.J. (Eds.), Neonatal-perinatal medicine. Mosby-Year Book, Inc., St. Louis, 1992, p. 1181-1198.
3. Pearce S.H., Trump D., Wooding C., Besser G.M., Chew S.L., Grant D.B., Heath D.A., Highes I.A., Paterson G.R., Whytem S. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J. Clin. Invest. 1995, 96: 2683-2692.
4. Bai M., Pearce S.H., Kifor O., Trivedi S., Stauffer U.G., Thakker R.V., Brown E.M., Steinmann B. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J. Clin. Invest. 1997, 99: 88-96.
5. Aarskog D., Harrison H. Disorders of calcium, phospate, PTH and vitamin D. In: Kappy M.S., Blizzard R.M., Migeon C.J. (Eds.), The diagnosis and treatment of endocrine disorders in childhood and adolescence. Charles C Thomas Publisher, Springfield, 1994, p. 1027-1092.
6. Bronsky D., Kiamko R.T., Moncada R., Rosenthal I.M. Intra-uterine hyperparathyroidism secondary to maternal hypoparathyroidism. Pediatrics 1968, 42: 606-613.
7. Anast C.S., David L. Human neonatal hypercalcemia. In: Holick M.F., Anast C.S., Gray T.K. (Eds.), Perinatal calcium and phosphorus metabolism. Elsevier Science Publishers, Amsterdam, 1983, pp. 363-366.
8. Fleischman A.R. Fetal parathyroid gland and calcium homeostasis. Clin. Obstet. Gynecol. 1980, 23: 791-802.
9. Landing B.H., Kamoshita S. Congenital hyperparathyroidism secondary to maternal hypoparathyroidism. J. Pediatr. 1970, 77: 842-847.
10. Stuart C., Aceto T., Kuhn J.P. Intrauterine hyperparathyroidism. Am. J. Dis. Child. 1979, 133: 67-70.
11. Black J.A., Bonham C., Carter R.E. Association between aortic stenosis and facies of severe infantile hypercalcemia. Lancet 1963, 2: 745-749.
12. Williams J.C.P., Barratt-Boyes B.G., Lowe J. Supravalvular aortic stenosis. Circulation 1961, 24: 1311-1318.
13. Harrison H.E., Harrison H.C. Disorders of calcium and phosphate metabolism in childhood and adolescence. W.B. Saunders, Philadelphia, 1979, p. 1-314.
14. Garabedian M., Jacqz E., Guillozo H., Grimberg R., Guillot M., Gagnadoux M.F., Broyer M., Lenoir G., Balsan S. Elevated plasma 1,25-Dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N. Engl. J. Med. 1985, 372: 948-952.
15. Lowery M.C., Morris C.A., Ewart A., Brothman L.J., Zhu X.L., Leonard C.O., Carey J.C., Keating M., Brothman A.R. Strong correlation of elastln deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am. J. Hum. Genet. 1995, 57: 49-53.
16. Aarskog D., Aksnes L., Markestad T. Vitamin D metabolism in idiopathic infantile hypercalcemia. Am. J. Dis. Child. 1981, 135: 1021-1024.
17. Martin N.D.T., Snodgrass G.J.A.I., Cohen R.D., Porteous C.E., Coldwell R.D., Trafford D.J.H., Makin H.L.J. Vitamin D metabolites in idiopathic infantile hypercalcemia. Arch. Dis. Child 1985, 60: 1140-1143.
18. Culler F.L., Jones K.L., Deftos L.J. Impaired calcitonin secretion in patients with William syndrome. J. Pediatr. 1985, 107: 720-723.
19. Hicks M.J., Levy M.L., Alexander J., Flaitz C.M. Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature. Pediatr. Dermatol. 1993, 10: 271-276.
20. Gu L.L., Daneman A., Binet A., Kooh S.W. Nephrocalcinosis and nephrolithiasis due to subcutaneous fat necrosis with hypercalcemia in two full-term asphyxiated neonates: sonographic finding. Pediatr. Radiol. 1995, 25: 142-144.
21. Finne P.H., Sanderud J., Aksnes L. Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis. J. Pediatr. 1988, 112: 792-794.
22. Kruse K., Irle U., Uhlig R. Elevated 1,25-dihydroxyvitamin D serum concentrations in infants with subcutaneous fat necrosis. J. Pediatr. 1993, 122: 460-463.
23. Bell N.H., Stern P.H. Pantzer E., Sinha T.K., DeLuca H.F. Evidence that increased circulating 1,25-dihydroxyvitamin D is a probable cause for abnormal calcium metabolism in sarcoidosis. J. Clin. Invest. 1979, 64: 218-225.
24. Reichel H., Koeffler H.P., Barbers R., Norman A.W. Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J. Clin. Endocrinol. Metab. 1987, 65: 1201-1209.
25. Gkonos P.J., London R., Hendler E.D. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N. Engl. J. Med. 1984, 311: 1683-1685.
26. Kantarjian H.M., Saad M.F., Estey E.H., Sellin R.V., Samaan N.A. Hypercalcemia in disseminated candidiasis. Am. J. Med. 1983, 74: 721-724.